G. Frederick Wilkinson

2014 - Impax Laboratories

In 2014, G. Frederick Wilkinson earned a total compensation of $13M as President and Chief Executive Officer at Impax Laboratories.

Compensation breakdown

Non-Equity Incentive Plan$862,793
Salary$552,500
Stock Awards$11,534,677
Other$28,900
Total$12,978,870

Wilkinson received $11.5M in stock awards, accounting for 89% of the total pay in 2014.

Wilkinson also received $862.8K in non-equity incentive plan, $552.5K in salary and $28.9K in other compensation.

Rankings

In 2014, G. Frederick Wilkinson's compensation ranked 316th out of 13,032 executives tracked by ExecPay. In other words, Wilkinson earned more than 97.6% of executives.

ClassificationRankingPercentile
All
316
out of 13,032
98th
Division
Manufacturing
120
out of 4,967
98th
Major group
Chemicals And Allied Products
41
out of 1,690
98th
Industry group
Drugs
32
out of 1,369
98th
Industry
Pharmaceutical Preparations
30
out of 1,042
97th
Source: SEC filing on April 14, 2015.

Wilkinson's colleagues

We found six more compensation records of executives who worked with G. Frederick Wilkinson at Impax Laboratories in 2014.

2014

Larry Hsu

Impax Laboratories

Chief Executive Officer

2014

Carole Ben-Maimon

Impax Laboratories

Former President, Impax Generics Division

2014

Michael Nestor

Impax Laboratories

President, Impax Specialty Pharma division

2014

Mark Schlossberg

Impax Laboratories

General Counsel

2014

Bryan Reasons

Impax Laboratories

Chief Financial Officer

2014

Jeffrey Nornhold

Impax Laboratories

Senior Vice President, Technical Operations

You may also like